1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) – Market, Industry, Trends, Technologies and Prospects 2015-2025

Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) – Market, Industry, Trends, Technologies and Prospects 2015-2025

  • September 2015
  • -
  • Visiongain
  • -
  • 327 pages

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Report Details
Contracted drug production – stay ahead now by exploring leading companies’ prospects
How are pharma contract manufacturing organisations (CMOs) performing? Visiongain’s updated report shows you their prospects to 2025. You discover that outsourcing industry’s results, trends, opportunities and potentials, also with predicted revenues and profits.

Our study analyses 30 top CMOs. There you see how revenues from drug production services can increase. You explore trends, technologies and opportunities shaping that industry. Discover that market’s potential, benefiting your reputation for commercial insight.

That way you find analysis on established and emerging companies across the world. Read on, please, to scan the leading companies and see revenue prediction for their industry.

Forecasts and other data to help you stay ahead, benefiting your influence
In our new study you find analytical profiles of 30 top contractors, and analyses of their overall industry. You discover historical data, market and sales shares, growth rates and revenue forecasts. Also explore qualitative analyses, business outlooks and developments.

Our study gives you 185 tables, 111 charts and three interviews with companies.

That investigation also shows you prospects for these outsourced production segments at world level, including their overall revenue forecasts to 2025:
- Active pharmaceutical ingredients (API) production
- Finished dosage formulations (FDF) manufacturing.



In particular, biologics and biosimilars hold promise. New therapies – including antibody-drug conjugates, high potency APIs and regenerative medicines – increasingly interest CMOs and clients.

Discover, then, what the future holds. The following sections highlight what our research and analyses give you, to benefit planning, proposals and presentations.

Company profiles – explore commercial activities, results, competition and prospects
Our report analyses 30 leading companies. The content of each profile differs, depending on the organisation. In general, though, a profile gives you the following information:
- Overview of the company’s contract manufacturing services and operations
- Analysis of recent financial performance – annual revenue for CMO services, including some data on operating profit and margins
- Assessment of developments – activities, acquisitions, production capacity, deals, new service offerings and collaborations
- SWOT analysis – a firm’s strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth from 2015 onwards
- Forecasting of pharmaceutical manufacturing revenue to 2025 (for 26 firms), as well as projected operating profit and margin for some companies.

Pharmaceutical developers, producers and marketers will increasingly use CMOs. With our study you discover what that industry’s participants offer – along with their trends and revenue potentials – helping you stay ahead in knowledge and benefit your authority.

European contract manufacturing organisations
Our study gives you discussions, financial analyses and commercial outlooks for 14 European CMOs, including these firms:
- Lonza
- Evonik Degussa
- Royal DSM
- Boehringer Ingelheim
- Fareva
- Famar
- Vetter Pharma.

Discover what the future holds for those pharma service providers, including revenue outlooks to 2025. What profitability and other achievements are possible?

CMOs based in the US and Japan
Our report also shows you developments and business outlooks for seven other international drug production contractors:
- Catalent Pharma Solutions
- Patheon
- Baxter BioPharma Solutions
- AbbVie Contract Manufacturing
- Pfizer CentreSource
- Daito Pharmaceutical
- Nipro Corporation.

Our work reveals where sales growth can occ

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 Summary Systemic Lupus Erythematosus (SLE) is a systemic inflammatory autoimmune disease ...

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2025 Summary Ulcerative Colitis (UC) is a type of chronic IBD that causes inflammation and ulcers in the innermost lining of ...

PharmaFocus: Tauopathies - Global Market Analysis

PharmaFocus: Tauopathies - Global Market Analysis

  • $ 9495
  • Industry report
  • February 2017
  • by GlobalData

PharmaFocus: Tauopathies - Global Market Analysis Summary Tauopathies are a class of more than 20 neurodegenerative diseases characterized by tau protein aggregation in the brain. There are currently no ...


Download Unlimited Documents from Trusted Public Sources

The future of the Pharmaceutical Industry in Africa

  • April 2017
    4 pages
  • Pharmaceutical  

  • Africa  

    World  

View report >

Therapy Market and Targeted Therapy Market in the UK

  • April 2017
    77 pages
  • Therapy  

    Targeted Therap...  

    Digestive Syste...  

  • United Kingdom  

View report >

Antifungal Industry in the US

  • April 2017
    4 pages
  • Antifungal  

  • United States  

    China  

View report >

Diabetes Statistics

17 days ago

Related Market Segments :

Pharmaceutical

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.